Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,940 public trials 1,514 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

NCT03653507

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Pacific Cancer Care Monterey, California, United States
  • University of Kansas Cancer Center and Medical Pavilion Fairway, Kansas, United States
  • Ochsner Clinic CCOP New Orleans, Louisiana, United States
  • New Mexico Oncology Hematology Albuquerque, New Mexico, United States
View all 165 locations
View Trial Details
Active, Not Recruiting

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

NCT04486378

Conditions
Colonic Diseases, Colorectal Cancer Stage II, Colorectal Cancer Stage III, +10 more
Locations
  • Marin Cancer Care Greenbrae, California, United States
  • Rocky Mountain Cancer Centers - Denver Midtwon Denver, Colorado, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Indianapolis, Indiana, United States
  • Allina Health Minneapolis, Minnesota, United States
View all 86 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

NCT06237920

Conditions
Antineoplastics Toxicity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Rijnstate Arnhem, Gelderland, Netherlands
  • Radboud University Medical Center Nijmegen, Gelderland, Netherlands
  • NKI-AVL Amsterdam, North Holland, Netherlands
  • Amsterdam UMC (AUMC) Amsterdam, North Holland, Netherlands
View Trial Details
Active, Not Recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

Conditions
Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • St. Joseph Hospital Orange, California, United States
  • Torrance Health Association Redondo Beach, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

NCT04964934

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Long Beach, California, United States
View all 264 locations
View Trial Details

Related conditions